Asad Y - Search Results

1

Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma.

Siskos AP, Jain P, Römisch-Margl W, Bennett M, Achaintre D, Asad Y, Marney L, Richardson L, Koulman A, Griffin JL, Raynaud F, Scalbert A, Adamski J, Prehn C, Keun HC. Siskos AP, et al. Among authors: asad y. Anal Chem. 2017 Jan 3;89(1):656-665. doi: 10.1021/acs.analchem.6b02930. Epub 2016 Dec 13. Anal Chem. 2017. PMID: 27959516 Free PMC article.

2

Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial.

Asad Y, Cropp G, Adams A, O'Donnell A, Raynaud F, Judson I, Workman P. Asad Y, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 25;785(1):175-86. doi: 10.1016/s1570-0232(02)00912-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12535850 Clinical Trial.

3

A validated liquid chromatographic-tandem mass spectroscopy method for the quantification of abiraterone acetate and abiraterone in human plasma.

Martins V, Asad Y, Wilsher N, Raynaud F. Martins V, et al. Among authors: asad y. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 7;843(2):262-7. doi: 10.1016/j.jchromb.2006.06.010. Epub 2006 Jun 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. PMID: 16809076

4

Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasma.

Moreno-Farre J, Asad Y, Pacey S, Workman P, Raynaud FI. Moreno-Farre J, et al. Among authors: asad y. Rapid Commun Mass Spectrom. 2006;20(19):2845-50. doi: 10.1002/rcm.2668. Rapid Commun Mass Spectrom. 2006. PMID: 16941534

5

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Pacey S, Gore M, Chao D, Banerji U, Larkin J, Sarker S, Owen K, Asad Y, Raynaud F, Walton M, Judson I, Workman P, Eisen T. Pacey S, et al. Among authors: asad y. Invest New Drugs. 2012 Feb;30(1):341-9. doi: 10.1007/s10637-010-9493-4. Epub 2010 Aug 5. Invest New Drugs. 2012. PMID: 20683637 Clinical Trial.

6

International Ring Trial of a High Resolution Targeted Metabolomics and Lipidomics Platform for Serum and Plasma Analysis.

Thompson JW, Adams KJ, Adamski J, Asad Y, Borts D, Bowden JA, Byram G, Dang V, Dunn WB, Fernandez F, Fiehn O, Gaul DA, Hühmer AF, Kalli A, Koal T, Koeniger S, Mandal R, Meier F, Naser FJ, O'Neil D, Pal A, Patti GJ, Pham-Tuan H, Prehn C, Raynaud FI, Shen T, Southam AD, St John-Williams L, Sulek K, Vasilopoulou CG, Viant M, Winder CL, Wishart D, Zhang L, Zheng J, Moseley MA. Thompson JW, et al. Among authors: asad y. Anal Chem. 2019 Nov 19;91(22):14407-14416. doi: 10.1021/acs.analchem.9b02908. Epub 2019 Nov 8. Anal Chem. 2019. PMID: 31638379 Free PMC article.

7

Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation.

Pal A, Asad Y, Ruddle R, Henley AT, Swales K, Decordova S, Eccles SA, Collins I, Garrett MD, De Bono J, Banerji U, Raynaud FI. Pal A, et al. Among authors: asad y. Metabolomics. 2020 Apr 13;16(4):50. doi: 10.1007/s11306-020-01676-0. Metabolomics. 2020. PMID: 32285223 Free PMC article. Clinical Trial.

8

Inter-Laboratory Robustness of Next-Generation Bile Acid Study in Mice and Humans: International Ring Trial Involving 12 Laboratories.

Pham HT, Arnhard K, Asad YJ, Deng L, Felder TK, St John-Williams L, Kaever V, Leadley M, Mitro N, Muccio S, Prehn C, Rauh M, Rolle-Kampczyk U, Thompson JW, Uhl O, Ulaszewska M, Vogeser M, Wishart DS, Koal T. Pham HT, et al. J Appl Lab Med. 2016 Sep 1;1(2):129-142. doi: 10.1373/jalm.2016.020537. J Appl Lab Med. 2016. PMID: 33626781

9

Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.

Naseem A, Pal A, Gowan S, Asad Y, Donovan A, Temesszentandrási-Ambrus C, Kis E, Gaborik Z, Bhalay G, Raynaud F. Naseem A, et al. Among authors: asad y. Cells. 2022 Oct 19;11(20):3286. doi: 10.3390/cells11203286. Cells. 2022. PMID: 36291153 Free PMC article.

10

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies.

Banerji U, O'Donnell A, Scurr M, Pacey S, Stapleton S, Asad Y, Simmons L, Maloney A, Raynaud F, Campbell M, Walton M, Lakhani S, Kaye S, Workman P, Judson I. Banerji U, et al. Among authors: asad y. J Clin Oncol. 2005 Jun 20;23(18):4152-61. doi: 10.1200/JCO.2005.00.612. J Clin Oncol. 2005. PMID: 15961763 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters